GlassScriptPhysician profile
Oscar D Aljure
NPI 1154640514
$3,243.80
in general payments reported to CMS, 2019-2025
8 companies · $979 in 2025
The $979 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $48.00 · 2022: $640 · 2023: $524 · 2024: $1,053 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,555.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $1,459.38 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,038.93 | 2023-2025 | Avalus, Mc3 Nautilus(Tm) Ecmo Oxygenator, Biomedicus |
| Edwards Lifesciences Corporation | $369.61 | 2021-2022 | |
| Becton, Dickinson and Company | $180.46 | 2024 | Hemosphere |
| Smith+Nephew, INC. | $72.26 | 2024-2025 | Pico 14 |
| Depuy Synthes Sales INC. | $70.87 | 2025 | Na, Matrixrib, Zipfix |
| Abbott Laboratories | $28.12 | 2023 | Navitor |
| Baudax Bio INC. | $24.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Aljure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.